scholarly journals Conference 2016: From Drug Discovery to Health Outcomes: Population to Patient. An international symposium held jointly by CSPS and CC-CRS, May 31-June 3, 2016, Vancouver, BC, Canada

2016 ◽  
Vol 19 (3) ◽  
pp. 1
Author(s):  
Beverley Berekoff
Keyword(s):  
Drug Discovery ◽  
Pharmaceutical Research ◽  
Lessons Learned ◽  
Knowledge Generation ◽  
Pharmaceutical Sciences ◽  
University Of Alberta ◽  
University Of Toronto ◽  
Lifetime Achievement ◽  
Life Sciences Industry ◽  
Pharmaceutical Research And Development

Plenaries and Special Presentations:Carolyn Buser-Doepner, GSK:  "New Trends in Pharma-Academia Collaborations for Drug Discovery"Chris Halyk, President, Janssen Inc.:  "Are Innovative Medicines and our Life Sciences Industry at Risk in Canada?"Aaron Schimmer, Princess Margaret Cancer Centre:  "New Therapeutic Strategies to Target the Mitochondria in Leukemia"Ivana Cecic, Genome BC:  "Genomics in Canada: From Knowledge Generation to Patient Outcomes"Adam Rosebrock, University of Toronto:  "Quantitative Mass-Spectrometry Metabolomics for Direct Biochemical Phenotyping"Fakhreddin Jamali, University of Alberta: CSPS Lifetime Achievement Award Lecture - "Pharmaceutical Research and Development, Lessons Learned"Conference Sessions:Special Session: Innovation and Management of Modern Pharmaceuticals1. Special Populations2. Nanomedicines Become Personal: Opportunities and Challenges3. Mucosal Drug Delivery4. Broaching the Fourth Hurdle: Getting Drugs on the Formulary5. Pharmacogenomics in the Clinic and Community6. Responsive Drug Delivery Systems7. Drug Targeting and Targeting Drugs8. Health Sustainability Evidence9. Integrating Pharmaceutical Sciences into a Pharm D Curriculum10. Analytical Innovation to Support Precision Medicine and Biologicals Development11. Protein and Peptide Delivery

scholarly journals Conference 2015: Drug Discovery and Development in the Post Genomic Era. An international symposium held jointly by CSPS and CC-CRS, May 26-28, 2015, Toronto, ON, Canada

2015 ◽  
Vol 18 (3) ◽  
pp. 1
Author(s):  
Beverley Berekoff
Keyword(s):  
Drug Discovery ◽  
Drug Targets ◽  
New Technologies ◽  
Pharmaceutical Sciences ◽  
Drug Discovery And Development ◽  
University Of Toronto ◽  
Genome Wide ◽  
Lifetime Achievement ◽  
New Methodologies ◽  
University Of Manitoba

Plenaries and Special Presentations:Shana Kelley, University of Toronto:  "New Technologies for Ultrasensitive Analysis of Clinically-relevant Biomolecules"Richard Hargreaves, BIOGEN IDEC:  "Imaging in CNS Drug Discovery and Development"Roger Williams:  CSPS Lifetime Achievement Award - "0.5 X 102:  Looking Back and Forward"Neal Davies, University of Manitoba:  CSPS Award of Leadership in Canadian Pharmaceutical Sciences - "30 Years of Coffee, Beer and Serendipity in Pharmacy Research"Conference Sessions:Special CSPS Session: The Future of Pharmaceutical Sciences1. The Evolving Business of Pharmaceuticals2. Analysis of Peptide and Protein Drug Targets by LC/MS/MS3. Mucosal Drug Delivery4. New Methodologies of Genome Wide Target Validation5. Regulatory Updates and Developments6. Antibody-based Therapeutics7. Imaging in Drug Delivery8. Nuclear Receptors in Drug Discovery9. IV-IVC Modeling and Simulation as a Tool to Facilitate Drug Development and Marketing10. Pharmacogenomics in Drug Development11. Bioavailability of Novel Dosage Forms

Miniaturized screening technologies for drug discovery

2002 ◽  
Vol 30 (4) ◽  
pp. 802-806 ◽  
Author(s):  
J. M. Cooper ◽  
A. E. G. Cass
Keyword(s):  
Drug Discovery ◽  
Molecular Biology ◽  
Pharmaceutical Research ◽  
Toxicity Assessment ◽  
Clinical Development ◽  
Biological Screening ◽  
Drug Candidates ◽  
The Us ◽  
Pharmaceutical Research And Development ◽  
Microsystems Technology

Adaptive Profiling (APL) and other biochip companies aim to harness the power of microsystems technology together with advances in chemistry and molecular biology, to become service and technology providers to organizations involved in pharmaceutical research and development. By supplying a unique range of decisionmaking tools that aid an earlier identification of qualified drug candidates for clinical development, the company should gain a significant share of the US$10 billion biological screening, bioavailability and toxicity assessment market.

James Bertram Collip, 1892-1965

1973 ◽  
Vol 19 ◽  
pp. 234-267 ◽  
Keyword(s):  
Family Life ◽  
Clinical Medicine ◽  
National Research Council ◽  
Pituitary Hormones ◽  
University Of Alberta ◽  
University Of Toronto ◽  
Mcgill University ◽  
Medical Importance ◽  
The University ◽  
Happy Family

James Bertram Collip was a pioneer in endocrine research, especially in its biochemical aspects. Following an excellent training in biochemistry under Professor A. B. Macallum, F.R.S., at the University of Toronto, he spent thirteen years at the University of Alberta in Edmonton. There was a momentous year at the University of Toronto about midway through the Edmonton period; this coincided with the discovery of insulin by Sir Frederick G. Banting, F.R.S., and Professor Charles S. Best, F.R.S., and the experience altered the course of his career. Henceforth, Professor Collip’s life was dominated by an urge to discover hormones that would be useful in clinical medicine. Success attended these efforts, first in the isolation of the parthyroid hormone, called parathormone, while he was at the University of Alberta and later in the identification of placental and pituitary hormones during particularly fruitful years at McGill University. There were other important facets to Professor Collip’s career. These included the training of young scientists, many of whom subsequently came to occupy positions of responsibility, work with the National Research Council of Canada, and in his latter years an important contribution as Dean of the Faculty of Medicine, University of Western Ontario. In addition to a life of fulfilment through accomplishments of scientific and medical importance, Professor Collip’s career was enriched by a happy family life and by the friendship of a host of individuals who were attracted to his brilliance as a scientist and his warm personality.

Sign in / Sign up

Export Citation Format

Share Document